Authored By: Sarah
26 Jun 2024

 Immunohematology Market Size to grow by USD 1065.7 million between 2024-2028

According to a research report “ Immunohematology Market” by Product (Analyzers and systems, Reagents) End-user (Hospitals, Blood banks, Diagnostic laboratories) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1065.7 million, at a CAGR of  7.35% during the forecast period. In the Immunohematology Market, leading manufacturers are innovating automated and semi-automated analyzers to streamline processes and minimize human errors. The escalating demand for blood transfusions in surgical procedures necessitates the adoption of advanced immunohematology technology. Tier 1 companies, including Immucor and Grifols, are responding to this need by developing automated immunology analyzers. For instance, Quidel Ortho's Ortho Optix Reader, a semi-automated blood bank analyzer, integrates with the Ortho Workstation to create a comprehensive immunohematology testing platform for small to mid-volume blood transfusion laboratories. These solutions enable blood banks and hospitals to efficiently manage their large inventories of blood units, reducing the reliance on manual methods and minimizing potential errors.

Browse market data tables, figures, and in-depth TOC on “Immunohematology Market” by Product (Analyzers and systems, Reagents) End-user (Hospitals, Blood banks, Diagnostic laboratories) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Product, the Analyzers and systems segment is projected to dominate the market size in 2024

In the Immunohematology Market, hospitals serve as significant buyers, driving market expansion. Major hospitals, including multispecialty hospitals and hospital groups, operate under government sponsorship or privately and possess over 500 hospital beds. These institutions cater to a substantial population and provide extensive inpatient and outpatient services, generating substantial revenues. With advanced medical infrastructure and a high volume of patients, they procure medical products and consumables in bulk, engaging closely with various stakeholders, such as suppliers, reimbursement authorities, and government organizations. Diagnosis and monitoring of many surgical procedures predominantly occur in outpatient departments within these hospitals.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024

The global immunohematology market is poised for significant growth due to the increasing demand for automated analyzers in large-scale blood banks and Tier 1 hospitals. For instance, the National Health Service Blood and Transplantation Center (NHSBT) in the UK stores over 900 gallons of blood and processes approximately 200-300 blood screenings daily for transfusion purposes. With over 11,000 weekly donations, the need for efficient and accurate immunohematology testing solutions is paramount. Automated analyzers offer time-saving benefits, enabling laboratories to process a higher volume of samples, thereby reducing workload and enhancing operational efficiency. The adoption of next-generation immunohematology analyzers with enhanced throughput is expected to revolutionize the market landscape.

North America is forecasted to hold the largest market size by region in 2024

The Immunohematology market encompasses the production and sale of diagnostic and therapeutic products utilized in the field of blood transfusion and immunology. Key offerings include blood typing reagents, antibodies, and complement components. Market growth is driven by increasing demand for safe and effective blood transfusions, advancements in diagnostic technologies, and a rising geriatric population requiring frequent transfusions. Companies such as Grifols, Thermo Fisher Scientific, and F. Hoffmann-La Roche dominate the market landscape.

The Immunohematology Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Becton Dickinson and Co.
  • Biomed Global
  • Bio Rad Laboratories Inc.
  • biosurfit SA
  • Cardinal Health Inc.
  • Calibre Scientific Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Hemo bioscience Inc.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Institut de Biotechnologies Jacques Boy
  • MAK SYSTEM S.A.
  • Merck KGaA
  • Mesa Laboratories Inc.
  • Quotient Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics Pvt. Ltd.
  • Werfenlife SA
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Immunohematology market has gained significant attention in the healthcare services sector due to the ongoing coronavirus pandemic and the increasing prevalence of various infections and blood associated diseases. The market space for immunohematology technologies, including blood component services and storage, has expanded as the demand for immunological testing and blood products has surged. Immunohematology tests play a crucial role in identifying antibodies and antigens in blood samples, which is essential for the safe administration of blood transfusions. These tests are used to detect HIV, pregnancy-related reactions, transplant-related reactions, and immunity-related reactions. The market for immunohematology technologies also includes the development of advanced technologies for the storage of blood products, such as red blood cells, which are susceptible to hemolysis. The Leukemia Foundation and PLOS One have published research on the importance of proper blood storage in preventing hemolysis and ensuring the safety of blood transfusions. The elective surgical procedures and trauma cases have also increased the demand for blood donation and blood transfusion services. Blood banks have become an integral part of the healthcare system, providing essential blood products to patients with various blood disorders, including sickle cell disease and hemophilia. Awareness campaigns are being conducted to promote blood donation and increase public awareness of the importance of immunohematology tests and blood transfusion services. The market for immunohematology technologies is expected to continue growing as the demand for safe and effective blood products increases.

Market Research Overview

The Immunohematology market encompasses a range of diagnostic tests and technologies used in the identification and analysis of various blood-borne infections, hematological diseases, and blood component services. This market caters to both public and private healthcare settings, with clinical trials ongoing to advance immunohematology technologies. Key components of the market include reagents, manual methods using gel cards, biochips, microplates, and semi-automatic or automatic analyzers. The market is driven by the increasing prevalence of diseases such as leukemia, lymphoma, thalassemia, and sickle cell anemia. The World Health Organization reports over 389,000 new leukemia cases and 301,000 deaths annually. Immunohematology devices, such as hematology analyzers, play a crucial role in diagnosis and treatment. These devices analyze various blood parameters, including viral load, RNA, and DNA, to detect genetic material and identify antigens and antibodies. Automation of devices, software up-gradation, increased storage capabilities, and the emergence of fully-automated devices have streamlined blood testing, processing, and collection. The market space is vast, with consumers including healthcare practitioners, emergency assistance services, trauma centers, and masses. The market faces challenges due to regulatory hurdles, hesitation from consumers, and the spread of infections like coronavirus. However, awareness programs, blood donation camps, and collaborations between public and private entities are driving growth. Immunohematology tests play a vital role in blood transfusion, diagnosing blood-borne infections like hepatitis, HIV, and pregnancy- or transplant-related reactions. Technologies like Polymerase chain reaction, DG Reader Net, Grifols, BioVue method, and ORTHO VISION Analyzer are transforming the market. The future of the market lies in the development of advanced technologies for blood processing, storage, and analysis, ensuring diagnosis efficacy and minimizing analysis time.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio